Search Results - Ravi Jahagirdar

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)

    Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208) by Sylwia Wasiak, Dean Gilham, Laura Tsujikawa, Christopher Halliday, Cyrus Calosing, Ravi Jahagirdar, Jan Johansson, Michael Sweeney, Norman C.W. Wong, Ewelina Kulikowski

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    RVX-208

    RVX-208 by Dana Bailey, Ravi Jahagirdar, Allan Gordon, Anouar Hafiane, Steven Campbell, Safia Chatur, Gregory S. Wagner, Henrik C. Hansen, Fabrizio S. Chiacchia, Jan Johansson, Larbi Krimbou, Norman C.W. Wong, Jacques Genest

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Apabetalone downregulates factors and pathways associated with vascular calcification

    Apabetalone downregulates factors and pathways associated with vascular calcification by Dean Gilham, Laura Tsujikawa, Christopher D. Sarsons, Christopher Halliday, Sylwia Wasiak, Stephanie C. Stotz, Ravi Jahagirdar, Michael Sweeney, Jan O. Johansson, Norman C.W. Wong, Kamyar Kalantar‐Zadeh, Ewelina Kulikowski

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease

    RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease by Ravi Jahagirdar, Sarah Attwell, Suzana Marušić, Alison M. Bendele, Narmada Shenoy, Kevin G. McLure, Dean Gilham, Karen Norek, Henrik C. Hansen, Raymond Yu, Jennifer Tobin, Gregory S. Wagner, Peter R. Young, Norman C.W. Wong, Ewelina Kulikowski

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension

    Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension by Diederik E. van der Feen, Kondababu Kurakula, Ève Tremblay, Olivier Boucherat, Guido P. L. Bossers, Robert Szulcek, Alice Bourgeois, Marie-Claude Lampron, Karima Habbout, Sandra Martineau, Roxane Paulin, Ewelina Kulikowski, Ravi Jahagirdar, Ingrid Schalij, Harm Jan Bogaard, Beatrijs Bartelds, Steeve Provencher, Rolf M.F. Berger, Sébastien Bonnet, Marie‐José Goumans

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: